Cleared Traditional

K931746 - LATEX (K82)

K931746 is the FDA 510(k) clearance for LATEX (K82) by Diagnostic Products Corp.. It is a Class 2 Immunology device (product code DHB) cleared through the Traditional 510(k) pathway after a 712-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1995
Decision
712d
Days
Class 2
Risk

K931746 is an FDA 510(k) clearance for the LATEX (K82). Classified as System, Test, Radioallergosorbent (rast) Immunological (product code DHB), Class II - Special Controls.

Submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on March 21, 1995 after a review of 712 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5750 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Immunology submissions.

View all Diagnostic Products Corp. devices

Submission Details

510(k) Number K931746 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 1993
Decision Date March 21, 1995
Days to Decision 712 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
608d slower than avg
Panel avg: 104d · This submission: 712d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DHB System, Test, Radioallergosorbent (rast) Immunological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHB System, Test, Radioallergosorbent (rast) Immunological

All 186
Devices cleared under the same product code (DHB) and FDA review panel - the closest regulatory comparables to K931746.
SPECIFIC IGE ULTRA-EIA
K945884 · Hycor Biomedical, Inc. · Jun 1995
HYCOR SPECIFIC IGE ENZYME IMMUNOASSAY
K945748 · Hycor Biomedical, Inc. · Jun 1995
ACCESS ALLERGENS - FEMATOPHAGOIDES FARINAE, CAT DANDER, TIMOTHY GRASS, AND ALTERNARIA ALTERNATA WHICH ARE SPECIFIC IGEZR
K950629 · Bio-Rad Laboratories, Inc. · May 1995
HY-TEC AUTOMATED EIA SYSTEM
K941278 · Hycor Biomedical, Inc. · Mar 1995
HONEY BEE, YELLOW JACKET, PAPER WASP, IMPORTED FIRE ANT
K943768 · Diagnostic Products Corp. · Mar 1995
SPECIFIC IGE EIA-ULTRA ASSAY
K941057 · Hycor Biomedical, Inc. · Jan 1995